Fred P Lampropoulos's most recent trade in Merit Medical Systems, Inc. was a trade of 400 Common Stock, No Par Value done at an average price of $95.6 . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 95.61 per share. | 10 Jun 2025 | 400 | 1,045,628 (1%) | 0% | 95.6 | 38,244 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 95.19 per share. | 05 Jun 2025 | 10,000 | 1,046,028 (1%) | 0% | 95.2 | 951,900 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 95.12 per share. | 30 May 2025 | 10,000 | 1,056,028 (1%) | 0% | 95.1 | 951,200 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 96.54 per share. | 27 May 2025 | 20,000 | 1,066,028 (1%) | 0% | 96.5 | 1,930,800 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 103.75 per share. | 05 Mar 2025 | 20,000 | 1,086,028 (1%) | 0% | 103.8 | 2,075,000 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 104.05 per share. | 05 Mar 2025 | 11,320 | 1,106,028 (2%) | 0% | 104.1 | 1,177,846 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 103.75 per share. | 05 Mar 2025 | 2,590 | 7,734 (0%) | 0% | 103.8 | 268,713 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 103.94 per share. | 05 Mar 2025 | 409 | 10,324 (0%) | 0% | 103.9 | 42,511 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, President and CEO | 27 Feb 2025 | 38,002 | 1,143,391 (2%) | 0% | 44.8 | 1,702,490 | Common Stock, No Par Value | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, President and CEO | 27 Feb 2025 | 38,002 | 0 | - | - | Non-qualified stock options (right to buy) | ||
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 30,755 | 1,098,506 (1%) | 0% | 0 | Common Stock, No Par Value | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, President and CEO | 27 Feb 2025 | 26,043 | 1,117,348 (2%) | 0% | 102.0 | 2,657,428 | Common Stock, No Par Value | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 20,384 | 1,105,389 (2%) | 0% | 0 | Common Stock, No Par Value | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.50 per share. | 27 Feb 2025 | 13,501 | 1,085,005 (1%) | 0% | 98.5 | 1,329,849 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, President and CEO | 27 Feb 2025 | 4,000 | 13,228 (0%) | 0% | 44.8 | 179,200 | Common Stock, No Par Value | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, President and CEO | 27 Feb 2025 | 4,000 | 0 | - | - | Non-qualified stock options (right to buy) | ||
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, President and CEO | 27 Feb 2025 | 2,494 | 10,734 (0%) | 0% | 102.0 | 254,488 | Common Stock, No Par Value | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 24,572 | 1,057,132 (1%) | 0% | 0 | Common Stock, No Par Value | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 18,962 | 1,076,094 (1%) | 0% | 0 | Common Stock, No Par Value | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.51 per share. | 04 Mar 2024 | 8,343 | 1,067,751 (1%) | 0% | 76.5 | 638,323 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.20 per share. | 25 Aug 2023 | 200,000 | 1,167,916 (2%) | 0% | 28.2 | 5,640,000 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 200,000 | 0 | - | - | Non-qualified stock options (right to buy) | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.19 per share. | 25 Aug 2023 | 135,356 | 1,032,560 (1%) | 0% | 67.2 | 9,094,570 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Aug 2023 | 6,000 | 0 | - | - | Non-qualified stock options (right to buy) | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.20 per share. | 25 Aug 2023 | 6,000 | 12,888 (0%) | 0% | 28.2 | 169,200 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 67.19 per share. | 25 Aug 2023 | 3,660 | 9,228 (0%) | 0% | 67.2 | 245,915 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 68.43 per share. | 14 Mar 2023 | 19,699 | 967,916 (1%) | 0% | 68.4 | 1,347,963 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 67.66 per share. | 14 Mar 2023 | 5,278 | 987,615 (1%) | 0% | 67.7 | 357,088 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 54,302 | 54,302 | - | - | Non-qualified stock options (right to buy) | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 27,159 | 1,025,582 (1%) | 0% | 0 | Common Stock, No Par Value | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 69.86 per share. | 28 Feb 2023 | 19,176 | 992,893 (1%) | 0% | 69.9 | 1,339,616 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.58 per share. | 28 Feb 2023 | 12,030 | 1,013,552 (1%) | 0% | 70.6 | 849,077 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 70.17 per share. | 28 Feb 2023 | 1,483 | 1,012,069 (1%) | 0% | 70.2 | 104,068 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.05 per share. | 10 Aug 2022 | 50,000 | 1,027,764 (1%) | 0% | 16.1 | 802,500 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2022 | 50,000 | 0 | - | - | Non-qualified stock options (right to buy) | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.16 per share. | 10 Aug 2022 | 29,341 | 998,423 (1%) | 0% | 62.2 | 1,823,837 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2022 | 6,000 | 0 | - | - | Non-qualified stock options (right to buy) | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.05 per share. | 10 Aug 2022 | 6,000 | 9,859 (0%) | 0% | 16.1 | 96,300 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.16 per share. | 10 Aug 2022 | 2,971 | 6,888 (0%) | 0% | 62.2 | 184,677 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2022 | 48,566 | 48,566 | - | - | Non-qualified stock options (right to buy) | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2022 | 17,680 | 985,596 (1%) | 0% | 0 | Common Stock, No Par Value | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.03 per share. | 26 Feb 2022 | 7,832 | 977,764 (1%) | 0% | 65.0 | 509,315 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2021 | 5,000 | 0 | - | - | Non-qualified stock options (right to buy) | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.27 per share. | 08 Sep 2021 | 5,000 | 6,269 (0%) | 0% | 17.3 | 86,350 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.23 per share. | 08 Sep 2021 | 2,410 | 3,859 (0%) | 0% | 72.2 | 174,074 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 58,083 | 58,083 | - | - | Non-qualified stock options (right to buy) | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 59.60 per share. | 12 Mar 2021 | 4,947 | 967,916 (1%) | 0% | 59.6 | 294,841 | Common Stock, No Par Value |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2021 | 8,840 | 976,756 (1%) | 0% | 0 | Common Stock, No Par Value | |
| Merit Medical Systems, Inc. | Fred P. Lampropoulos | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.72 per share. | 26 Feb 2021 | 3,893 | 972,863 (1%) | 0% | 55.7 | 216,918 | Common Stock, No Par Value |